Article Information
PMID
Published By
Print ISSN
0250-7005
Online ISSN
1791-7530
History
- Received October 27, 2020
- Revision received November 14, 2020
- Accepted November 17, 2020
- Published online December 7, 2020.
Copyright & Usage
Copyright © 2020 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Author Information
- PIRKKO-LIISA KELLOKUMPU-LEHTINEN⇑1,
- TIMO MARTTILA2,
- ANTTI JEKUNEN3,
- PETTERI HERVONEN4,
- KATARIINA KLINTRUP5,
- VESA KATAJA6,
- TAPIO UTRIAINEN7,
- MARJAANA LUUKKAA8,
- MARKKU LESKINEN2,
- KALEVI PULKKANEN6,
- ANNA-LIISA KAUTIO4 and
- TEPPO HUTTUNEN9
- 1Faculty of Medicine and Health Technology, University of Tampere and Center of Research, Development and Innovation, Tays Cancer Center, Tampere University Hospital, Tampere, Finland;
- 2Department of Urology, Seinäjoki Central Hospital, Seinäjoki, Finland
- 3Department of Oncology, Turku University, Vaasa Central Hospital, Vaasa, Finland;
- 4Department of Oncology, Tampere University Hospital, Tampere, Finland
- 5Department of Oncology, Oulu University Hospital, Oulu, Finland
- 6Department of Oncology, Kuopio University Hospital, Kuopio, Finland
- 7Comprehensive Cancer Center, Helsinki University Central Hospital, Helsinki, Finland
- 8Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland;
- 94Pharma Ltd., Turku, Finland
- Correspondence to: Pirkko-Liisa Kellokumpu-Lehtinen, MD, Ph.D., Professor emerita, Faculty of Medicine and Health Technology, University of Tampere, BOX 2000, 33101 Tampere, Finland. Tel: +35 8505951103, e-mail: pirkko-liisa.kellokumpu-lehtinen{at}tuni.fi
